Skip to content

Relmada Therapeutics, Inc. RLMD Issuance Of Restricted Common Stock

Issuance Of Restricted Common Stock at other companies

Hut 8 Mining Corp. logo
Hut 8 Mining Corp.HUT
$2K0.0%
US Physical Therapy logo
US Physical TherapyUSPH
$0-100%
Sharplink, Inc.
 logo
Sharplink, Inc. SBET
$572.5K+410%
AMC Networks Inc. logo
AMC Networks Inc.AMCX
$0
Rocket Lab USA, Inc. logo
Rocket Lab USA, Inc.RKLB
$49.26M
Lincoln National logo
Lincoln NationalLNC
$23M+475%

Other financials

Income statement

See full
Operating income-$19.5M-6.8%
Net income-$19.1M-8.5%
EPS (diluted)-$0.22+62.1%

Balance sheet

See full
Cash & equivalents$9.8M+750%
Total debt$104.1M-40.4%
Total equity$218.7M+875%
Total assets$235.4M+750%

Cash flow

See full
Operating cash flow-$15.1M+16.6%

Valuation

See full
Market cap$677.17M+2,907%

Returns & leverage

See full
Return on equity-48.8%-20.0pp
Debt / equity0.9×0.0×
Current ratio18.3×+13.0×

Where this comes from

Reported directly by Relmada Therapeutics, Inc. in its filing.

Tagged under the XBRL concept rlmd:IssuanceOfRestrictedCommonStock.

The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relmada Therapeutics, Inc.'s issuance of restricted common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Relmada Therapeutics, Inc.'s issuance of restricted common stock?
Relmada Therapeutics, Inc. (RLMD) reported issuance of restricted common stock of $905.23K in Q1 2025.
What does issuance of restricted common stock mean?
The value of common stock issued under restricted stock plans, representing a form of non-cash compensation. This metric tracks the utilization of equity to compensate staff without immediate cash outflows, impacting overall shareholder dilution.